|
|
| Antalgiques > Etude de marché sectorielle |
|
|
|
|
€ 2 699,00 |
Editeur
: |
Global Industry Analyst |
Langue
: |
Anglais |
Date de publication : |
Janvier 2006 |
Taille du document : |
651 |
Autres informations : |
Description , Table des matières |
| |
|
|
|
|
| |
Documents Publics |
1,200,000
documents |
Téléchargement illimités |
|
|
|
Etudes Privées |
50,000 rapports et études |
Paiement à la piéce |
|
|
|
|
| |
|
1.Télécharger nos rapports publics
Accés complet à plus de 1,2 Million de documents publics : études de marché, statistiques sectorielles, fiches pays, monographie d'entreprises, veille concurentielle, rapports annuels...
|
| Nos documents publics sur le même théme (1) |
|
|
|
| 48 pages | Décembre 2006 | Anglais
|
|
|
| Main
focus: |
hospital,emergency,hospitals,medical hospital,...
|
| Research
focus: |
competition analysis,market definition, |
| Geographic
focus: |
usa,india,mexico,france,united kingdom |
| |
|
|
|
|
| Autres recherches sur le même thème |
|
|
|
| |
| |
|
| |
|
2.
Rechercher d'autres rapports et études à commander
Rechercher et commander ici parmi 50.000 études de marché publiées par les principaux instituts d'études internationaux
|
| Rapports privés en relation |
|
Opioid Abuse - Hooked on Generics?
42 pages | Décembre 2005 |
IntroductionOpioid abuse is a growing medical challenge, yet few developments have been made in its treatment in recent years.
The market requires clarification of the goals of therapy - to remove |
3 230,00 €
|
| |
| |
US Internal Analgesics 2004
14 pages | Juillet 2004 |
Snapdata's US Internal Analgesics 2004 report provides 2003 year-end market data, with 2004 estimates and five-year forecasts.
The report gives an instant overview of the US internal analgesic mark |
240,00 €
|
| |
| |
Commercial Insight: Neuropathic Pain - A Plethora of Patient Segmentation and Product Differentiation Opportunities
131 pages | Juillet 2006 |
IntroductionNeurontin (gabapentin) has finally been knocked off the top spot as a result of fierce generic incursion.
However, Pfizer's follow-on Lyrica (pregabalin), Lilly's Cymbalta (duloxetine) |
12 160,00 €
|
| |
| |
OTC Analgesics in the United States
10 pages | Juin 2005 |
Euromonitor International’s ‘OTC Analgesics in the United States' Major Market Profile report offers an introduction to the market.
It is c.
10 pages long and provides a top line overview of sa |
198,00 €
|
| |
| |
US Analgesics 2004
14 pages | Juillet 2004 |
Snapdata's US Analgesics 2004 report provides 2003 year-end market data, with 2004 estimates and five-year forecasts.
The report gives an instant overview of the US analgesic market, and covers non |
240,00 €
|
| |
| |
Drug Safety in the Post-Vioxx Era: New legislation, regulation and company strategies in Europe and the US
175 pages | Juillet 2005 |
The new report, Drug Safety in the Post-Vioxx Era: New legislation, regulation and company strategies in Europe and the US, examines the actions taken by legislative and regulatory bodies in response |
1 520,00 €
|
| |
| |
Disease and Therapy Review: Migraine
9 pages | Février 2007 |
The Migraine Disease and Therapy Review provides prevalence numbers and percentages for major countries worldwide.
Diagnosis of migraine is covered, along with information on treatment options for |
720,00 €
|
| |
| |
Pain Management
459 pages | Janvier 2006 |
This report analyzes the worldwide markets for Pain Management in Millions of US$.
The specific product segments analyzed are Pain Management Pharmaceuticals, Pain Management Devices, and Pain Mana |
3 091,00 €
|
| |
| |
US State Market Index: Antacids
12 pages | Juillet 2006 |
The metrics in this report cover three year trends in Antacids [Manufacturing sector], broken out on a state-by-state basis.
Analysis is based on data applied from 1 industry firms.
Industry mar |
475,00 €
|
| |
| |
US Analgesics 2005
14 pages | Juin 2005 |
Snapdata's US Antacids 2005 report provides 2004 year-end market data, with 2005 estimates and five-year forecasts.
The report gives an instant overview of the US antacid market, and covers antacid |
240,00 €
|
| |
| |
|
| |
| Autres secteurs en relation |
|
|
|
| |
|
| |
| |
| Présentation de l'étude de marché - Description & Table des matières |
|
|
|
This report analyzes the worldwide markets for Analgesics in Millions of US$. The major product segments analyzed are Internal Analgesics, and External Analgesics. The sub-product segments discussed include Aspirin, Acetaminophen, and Ibuprofen. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World. Annual forecasts are provided for each region and product segment for the period of 2001 through 2010. A ten-year historic analysis is also provided for these markets with annual market analytics. The report profiles 186 companies including players worldwide such as Bayer’s Consumer Care Division, Bristol-Myers Squibb Co., Gelstat Corp., Johnson & Johnson, McNeil Consumer Healthcare, Naturopathic Laboratories International, Inc., Novartis AG, Pfizer, Inc., Reckitt Benckiser, Taro Consumer Healthcare, W. F. Young, Inc., Wyeth, and Wyeth Consumer Healthcare.
|
|
|
PPLSEN
|
|
|
|
|
